Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. | N Engl J Med;384(16): 1576-1577, 2021 04 22. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

Skowronski, Danuta M; De Serres, Gaston.

Skowronski DM; British Columbia Centre for Disease Control, Vancouver, BC, Canada danuta.skowronski@bccdc.ca.
De Serres G; Institut National de Santé Publique du Québec, Quebec City, QC, Canada.

N Engl J Med ; 384(16): 1576-1577, 2021 04 22.

Article in English | MEDLINE | ID: covidwho-1087536

Subject(s)

COVID-19 Vaccines; COVID-19; BNT162 Vaccine; Humans; RNA, Messenger; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: N Engl J Med Year: 2021 Document Type: Article Affiliation country: NEJMc2036242

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: N Engl J Med Year: 2021 Document Type: Article Affiliation country: NEJMc2036242